Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between plasminogen activator inhibitor‐1 and severity of liver injury and cardiovascular risk in children with non‐alcoholic fatty liver disease
Ran Jin, Alyssa M. Krasinskas, N‐A. Le, et al.
Pediatric Obesity (2016) Vol. 13, Iss. 1, pp. 23-29
Closed Access | Times Cited: 24

Showing 24 citing articles:

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients
Luz María Medrano, Pilar García‐Broncano, Juan Berenguer, et al.
AIDS (2018) Vol. 32, Iss. 9, pp. 1095-1105
Open Access | Times Cited: 39
Risk factors and predictive biomarkers of early cardiovascular disease in obese youth
Howard Chong Huat Ho, Ernesto Maddaloni, Raffaella Buzzetti
Diabetes/Metabolism Research and Reviews (2019) Vol. 35, Iss. 4
Closed Access | Times Cited: 38
Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease
Alessandro Ciavarella, Davide Gnocchi, Carlo Custodero, et al.
Thrombosis Research (2020) Vol. 198, pp. 139-150
Closed Access | Times Cited: 33
Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD
Pengyi Zhang, Weiya Wang, Min Mao, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 30
Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
Kaitlin Day, Lucia A. Seale, Ross M. Graham, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 30
Relationship Between Estimated Glucose Disposal Rate and Type 2 Diabetic Retinopathy
Cuiqiao Meng, Yuling Xing, Lijing Huo, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 807-818
Open Access | Times Cited: 11
Effects of resveratrol supplementation on serum concentrations of plasminogen activator inhibitor-1, fibroblast growth factor 21, and adiponectin in patients with nonalcoholic fatty liver disease
Laleh Farzin, Elahe Mansouri, Shiva Salehi, et al.
BMC Nutrition (2025) Vol. 11, Iss. 1
Open Access
Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints
Adam Buckley, E. Louise Thomas, Nader Lessan, et al.
Diabetes Research and Clinical Practice (2018) Vol. 144, pp. 144-152
Open Access | Times Cited: 30
A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease
Miriam B. Vos, Ran Jin, Juna V. Konomi, et al.
Pilot and Feasibility Studies (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 20
Noninvasive diagnostic tools for pediatric NAFLD: where are we now?
Antonella Mosca, Nadia Panera, Annalisa Crudele, et al.
Expert Review of Gastroenterology & Hepatology (2020) Vol. 14, Iss. 11, pp. 1035-1046
Closed Access | Times Cited: 16
Hepatic gene expression variations in response to high-fat diet-induced impaired glucose tolerance using RNAseq analysis in collaborative cross mouse population
H. J. Abu-Toamih Atamni, Georgia Kontogianni, Ilona Binenbaum, et al.
Mammalian Genome (2019) Vol. 30, Iss. 9-10, pp. 260-275
Closed Access | Times Cited: 17
Plasminogen Activator Inhibitor-1 Levels in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Hasan Alsharoh, Abdulrahman Ismaiel, Daniel-Corneliu Leucuța, et al.
Journal of Gastrointestinal and Liver Diseases (2022) Vol. 31, Iss. 2, pp. 206-214
Open Access | Times Cited: 9
Changes of Circulating Extracellular Vesicles from the Liver after Roux-en-Y Bariatric Surgery
Gersina Rega‐Kaun, Dorothea Ritzel, Christoph Kaun, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2153-2153
Open Access | Times Cited: 12
Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis
Larisse Longo, Pabulo Henrique Rampelotto, Eduardo Cremonese Filippi–Chiela, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 12, pp. 2052-2070
Open Access | Times Cited: 11
Association between plasminogen activator inhibitor‐1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA
Patrick Campbell, Lisa B. VanWagner, Laura A. Colangelo, et al.
Liver International (2020) Vol. 40, Iss. 5, pp. 1111-1120
Open Access | Times Cited: 10
A novel approach to childhood obesity: circulating chemokines and growth factors as biomarkers of insulin resistance
Patricia Rivera, Gabriel Ángel Martos‐Moreno, Vicente Barrios, et al.
Pediatric Obesity (2018) Vol. 14, Iss. 3
Closed Access | Times Cited: 9
Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease
Hang Gong, Zhong Huang, Huimei Xu, et al.
European Journal of Internal Medicine (2023) Vol. 114, pp. 23-34
Closed Access | Times Cited: 2
Screening New Blood Indicators for Non-alcoholic Fatty Liver Disease (NAFLD) Diagnosis of Chinese Based on Machine Learning
Cheng Wang, Junbin Yan, Shuo Zhang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Insights into the molecular mechanisms of Huangqi decoction on liver fibrosis via computational systems pharmacology approaches
Biting Wang, Zengrui Wu, Weihua Li, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Role of PAI-1 in Pediatric Obesity and Nonalcoholic Fatty Liver Disease
Ran Jin, Jennifer K. Frediani, Jeffery Holzberg, et al.
Current Cardiovascular Risk Reports (2017) Vol. 11, Iss. 3
Closed Access | Times Cited: 1
Insights into the molecular mechanisms of Huangqi decoction on liver fibrosis via computational systems pharmacology approaches
Biting Wang, Zengrui Wu, Weihua Li, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Increased Level of The Plasminogen Activator Inhibitor Type-1 is Associated with Severity of NAFLD
Didik Indiarso, Agung Prasetyo, Hirlan Hirlan, et al.
Journal of Biomedicine and Translational Research (2023) Vol. 9, Iss. 2, pp. 47-54
Open Access
The Effects of Regular Aerobic Exercise on the Serum levels of Plasminogen Activator Inhibitor-1 and Adiponectin in Obese Girls
Masoumeh Habibian, Seyed Abdolvahab Rezaye Mousavi
The Journal of Qazvin University of Medical Sciences (2019), pp. 418-429
Open Access
The Relation Between Non-alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease
Seyed Moayed Alavian, Hosein Zadi
Multidisciplinary Cardiovascular Annals (2022) Vol. 13, Iss. 1
Open Access
Page 1

Scroll to top